Business Wire

LGM Pharma’s Unique Mix of API Sourcing and CDMO Services Is Fueling Robust Growth

BOCA RATON, Fla.--(BUSINESS WIRE)--LGM Pharma, a leading provider of tailored API and CDMO services for the full drug product life cycle, today reported that its unique mix of active pharmaceutical ...
Yahoo Finance

Active Pharmaceutical Ingredients (API) Market to Surpass US$ 428.5 Billion by 2033 as Biotech APIs and Oncology Applications Lead Global Growth | DataM Intelligence

AUSTIN, Texas and TOKYO, Oct. 3, 2025 /PRNewswire/ -- According to DataM Intelligence, the Active Pharmaceutical Ingredients Market Size reached US$ 238.7 Billion in 2024, up from US$ 224.7 Billion in ...
PharmTech

CPHI 2025 Awards Spotlight Breakthroughs in Pharmaceutical Manufacturing and API Development

CPHI Pharma Awards 2025 recognized innovations in bio/pharmaceutical development, emphasizing sustainability, drug delivery, and supply chain resilience. Notable winners included Corden Pharma for ...
PR Newswire

Active Pharmaceutical Ingredients (API) Market Outlook 2028, the Market to Witness Investment of USD 312.37 Billion in the Next 6 Years - Arizton

Arizton Advisory and Intelligence is an innovative and quality-driven firm that offers cutting-edge research solutions to clients worldwide. We excel in providing comprehensive market intelligence ...
PR Newswire

Active Pharmaceutical Ingredients (API) Market worth $198.39 billion by 2030 with 6.6% CAGR | MarketsandMarkets™

The traditional APIs segment accounted for the largest share in 2024, whereas the HPAPI segment is expected to grow at the fastest CAGR over the forecast period. The HPAPI segment is further segmented ...